Adjuvant Treatment

Irving, Texas, USA, August 8, 2026 Caris Life Sciences® announced that the University of New Mexico Comprehensive Cancer Center...

San Diego, California, USA, August 8, 2026 Neurocrine Biosciences, Inc. has initiated a Phase 1 first-in-human clinical study evaluating...

Toronto, Ontario, Canada, August 8, 2026 Regeneron Canada Company announced that Health Canada has approved Libtayo® (cemiplimab for injection)...